RxDoctor Payments Data

Jeffery Grizzaffi

Foot & Ankle Surgery · Lafayette, LANPI 1508000381

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 99 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. That places this record below the midpoint for foot & ankle surgery clinicians in LA, where the typical reported total is $2,260.

$2,324in general payments, 2019–2025

Across 99 payments — averaging $23.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$336
  • Pfizer$285
  • Paratek Pharmaceuticals, Inc.$213
  • Convatec Inc.$169
  • Smith+Nephew$156
  • Ossio Inc$138
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$2,324100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,324 in reported general payments places this provider in the 50th percentile of 92 foot & ankle surgery providers in Louisiana.

See all foot & ankle surgery providers in Louisiana

Medicare billing

Part B allowed, 2024
$442,891
Medicare patients
578
Services billed
4,498

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin508$8,725
Duloxetine Hcl263$5,589
Pregabalin221$3,760
Methylprednisolone199$1,185
Triamcinolone Acetonide41$818
Naproxen69$468
Mupirocin40$365
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav28$278
Celecoxib13$247
Ciclopirox11$240
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen42$232
Ciprofloxacin Hcl27$231
Colchicine13$197
Tramadol Hcl34$103
Sodium Chloride0.9 % Sodium Chloride15$68

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Lafayette

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →